CMA Seeks To Appeal Re-Do Of £70M Pfizer, Flynn Drug Fines
The Competition and Markets Authority sought permission from the Court of Appeal on Tuesday to challenge a decision that criticized and revised the £70 million ($96 million) in fines it issued to...To view the full article, register now.
Already a subscriber? Click here to view full article